---
title: "GlucoTrack climbs 1% in regular trading on Lokahi Therapeutics deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292779080.md"
description: "GlucoTrack gains 1.4% to $0.54 in regular trading after completing strategic merger with Lokahi Therapeutics."
datetime: "2026-07-15T13:52:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292779080.md)
  - [en](https://longbridge.com/en/news/292779080.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292779080.md)
generator: "portal-rs"
---

# GlucoTrack climbs 1% in regular trading on Lokahi Therapeutics deal

GlucoTrack(GCTK.US) 盘中涨超 1%，现报 0.5365 美元。该股当日涨跌幅为 1.40%，短期波动显著。

消息面上，公司宣布已完成与 Lokahi Therapeutics 的战略业务合并。

### Related Stocks

- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)

## Related News & Research

- [GlucoTrack amends 8-K to add accountant review report for Lokahi interim financials](https://longbridge.com/en/news/297366213.md)
- [GlucoTrack Executes Reverse Stock Split to Restructure Shares](https://longbridge.com/en/news/297372174.md)
- [GlucoTrack to enact 1-for-15 reverse stock split Aug. 31](https://longbridge.com/en/news/297181503.md)
- [GlucoTrack unit Lokahi Therapeutics starts GMP manufacturing for LT-100 osteoarthritis pain candidate](https://longbridge.com/en/news/296910729.md)
- [GlucoTrack unit Lokahi Therapeutics expands ai2 Futures Lab collaboration with University of Georgia](https://longbridge.com/en/news/296614954.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**